Source: Annual Congress 2011 - Epithelial cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Pace, V. Scafidi, D. Di Bona, L. Siena, G. Chiappara, M. Ferraro, S. La Grutta, S. Gallina, R. Speciale, A. Ballacchino, C. Bachert, J. Bousquet, M. Gjomarkaj (Palermo, Italy; Ghent, Belgium; Montpellier, France). Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps. Eur Respir J 2011; 38: Suppl. 55, 3085

Member's Comments

No comment yet.

Related content which might interest you: IL-19 as putative biomarker for chronic rhinosinusitis with nasal polyps Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Immunoregulation and FoxP3 expression in the bronchial mucosa of stable COPD patients Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Nasal mucosa biopsy in patients with severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Basement membrane thickness, eosinophilic inflammation and urinary LTE4 in patients with nasal polyps with or without bronchial asthma Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 NOTCH-1 activation sustains hyperexpression of IL-33 in the epithelium of nasal polyps Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002 Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 MUC4 overexpression correlates corticoid resistance in chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Inflammatory features of nasal mucosa in smokers with and without COPD Source: Eur Respir J 2003; 22: Suppl. 45, 549s Year: 2003 Role of non cholinergic system components in chronic rhinosinusitis and nasal polyps Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Nasal mucosa biopsy in severe astma patiens as a tool for the prediction of the inflammatory changes in lower airways Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010